Dr. Kenneth Kim
Dr. Kenneth Kim
He currently is the CEO of Ark Clinical Research, a leading research site for COVID vaccines and treatments, and the CEO of Cosmos Health Solutions, a leading provider of coronavirus testing and treatment solutions for corporate clients, government agencies, schools, and the general public. He is also a strategic investor in a variety of startups, while also maintaining a private allergy and asthma practice in southern California.
Dr. Kenneth Kim, a summa cum laude graduate of Harvard College, received his MD from Harvard Medical School. Following a fellowship at the MIT Sloan School of Management, he completed his internal medicine and allergy/immunology training at UCLA. He has served on the clinical faculty both at UCLA and UCI Schools of Medicine for over 15 years.
Dr. Kim has served as a medical monitor, consultant, and investigator on over 800 clinical trials, having published over 30 research articles and 50 abstracts in peer reviewed journals. He has presented to decision makers in the FDA, the PMDA, SFDA, and KFDA. He is a nationally recognized expert in the areas of early stage clinical research, ethnobridging drug development strategy, influenza challenge, mold allergy, latex allergy, and COVID vaccine and treatments.
Over the years he has founded numerous health care services businesses including a 200+ employee clinical CRO which he transitioned to private equity groups twice. In his last investment, he served on the board of clinical trials digital media marketing company that was bought by a private equity firm.
He currently serves as a board member of the Go Campaign, a national nonprofit that champions pioneering local heroes who are transforming the lives of children in their communities across the world, on the President’s Leadership Council for Searching for Common Ground, the largest peacebuilding organization in the world focused on reconciliation and trust building and on the board of OC Human Relations, an organization implementing human relations programs in schools, cities, and corporations in Orange County. For the state of California, he sits as on the Governor’s advisory council for the California Initiative to Advance Precision Medicine and co chairs the Equitable Consent working group.